Clinical Trials: Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

Share this article:

Sponsor and Collaborators

National Cancer Institute (NCI)

Contact

NCI Referral Office

1-888-NCI-1937

ncicssc@mail.nih.gov

Principal Investigator

None indicated

ClinicalTrials.gov Identifier

NCT00942877

Share this article:
You must be a registered member of ONA to post a comment.
close

Next Article in Sarcoma Clinical Trials

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs